The milk-derived peptides Val-Pro-Pro and Ile-Pro-Pro attenuate arterial dysfunction in L-NAME-treated rats

摘要

Both endothelial dysfunction and arterial stiffness are surrogate markers of atherosclerosis and thus cardiovascular (CV) events. The milk-derived peptides Val-Pro-Pro (VPP) and Ile-Pro-Pro (IPP) inhibit angiotensin-converting enzyme, dilate blood vessels ex vivo and stimulate nitric oxide (NO) production in cells. In this study, we investigated the effects of either VPP or IPP on arterial function and on target organ damage in vivo. Male Wistar rats were treated with N(G)-nitro-L-arginine methyl ester hydrochloride (l-NAME, lgl~-1), l-NAME + VPP (0.3gI~-1) or L-NAME + IPP (0.3gI~-1) in their drinking water for 8 weeks. Plasma nitrite and nitrate (NOx) levels were significantly increased in normal Wistar rats after supplementation with either VPP or IPP but not in rats that were chronically treated with l-NAME. Acetylcholine-induced vasorelaxation in the thoracic aorta ring was impaired by l-NAME, whereas vasorelaxation was significantly greater in mice treated with l-NAME + VPP for 1 or 4 weeks or L-NAME + IPP for 4 weeks than in mice treated with l-NAME alone. Four weeks of treatment with either VPP or IPP attenuated the increase in pulse wave velocity (PWV) that was induced by l-NAME. Cardiac and renal damage were observed after 8 weeks of treatment with l-NAME, and either VPP or IPP attenuated this damage. These results show that VPP or IPP attenuates arterial dysfunction and suggest that milk-derived peptides might prevent CV damage.